ReviewCurrent oncology reports2022

Resistance to Poly (ADP-Ribose) Polymerase Inhibitors (PARPi): Mechanisms and Potential to Reverse.

Christina R Washington et al.PubMed ↗Publisher ↗

No numbers read from the abstract.